1
|
Koo SH and Montminy M: In vino veritas: A
tale of two sirt1s? Cell. 127:1091–1093. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wang H, Yang YJ, Qian HY, Zhang Q, Xu H
and Li JJ: Resveratrol in cardiovascular disease: What is known
from current research? Heart Fail Rev. 17:437–448. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Naderali EK, Doyle PJ and Williams G:
Resveratrol induces vasorelaxation of mesenteric and uterine
arteries from female guinea-pigs. Clin Sci (Lond). 98:537–543.
2000. View Article : Google Scholar : PubMed/NCBI
|
4
|
Soylemez S, Gurdal H, Sepici A and Akar F:
The effect of long-term resveratrol treatment on relaxation to
estrogen in aortae from male and female rats: Role of nitric oxide
and superoxide. Vascul Pharmacol. 49:97–105. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Taguchi K, Hida M, Matsumoto T and
Kobayashi T: Resveratrol ameliorates clonidine-induced
endothelium-dependent relaxation involving Akt and endothelial
nitric oxide synthase regulation in type 2 diabetic mice. Biol
Pharm Bull. 38:1864–1872. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Novakovic A, Bukarica LG, Kanjuh V and
Heinle H: Potassium channels-mediated vasorelaxation of rat aorta
induced by resveratrol. Basic Clin Pharmacol Toxicol. 99:360–364.
2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Shen M, Zhao L, Wu RX, Yue SQ and Pei JM:
The vasorelaxing effect of resveratrol on abdominal aorta from rats
and its underlying mechanisms. Vascul Pharmacol. 58:64–70. 2013.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang HY, Xu CQ, Li HZ, Li BX, Zhang YQ
and Zhang YN: Effects of resveratrol on isolated thoracic aorta
rings of rats. Zhongguo Zhong Yao Za Zhi. 30:1283–1286. 2005.(In
Chinese). PubMed/NCBI
|
9
|
Novakovic A, Gojkovic-Bukarica L, Peric M,
Nezic D, Djukanovic B, Markovic-Lipkovski J and Heinle H: The
mechanism of endothelium-independent relaxation induced by the wine
polyphenol resveratrol in human internal mammary artery. J
Pharmacol Sci. 101:85–90. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gojkovic-Bukarica L, Novakovic A, Kanjuh
V, Bumbasirevic M, Lesic A and Heinle H: A role of ion channels in
the endothelium-independent relaxation of rat mesenteric artery
induced by resveratrol. J Pharmacol Sci. 108:124–130. 2008.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Naderali EK, Smith SL, Doyle PJ and
Williams G: The mechanism of resveratrol-induced vasorelaxation
differs in the mesenteric resistance arteries of lean andobese
rats. Clin Sci (Lond). 100:55–60. 2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Li HF, Tian ZF, Qiu XQ, Wu JX, Zhang P and
Jia ZJ: A study of mechanisms involved in vasodilatation induced by
resveratrol in isolated porcine coronary artery. Physiol Res.
55:365–372. 2006.PubMed/NCBI
|
13
|
Mathiassen ON, Buus NH, Sihm I, Thybo NK,
Mørn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany
MJ and Christensen KL: Small artery structure is an independent
predictor of cardiovascular events in essential hypertension. J
Hypertens. 25:1021–1026. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cao YX, Zhang W, He JY, He LC and Xu CB:
Ligustilide induces vasodilatation via inhibiting voltage dependent
calcium channel and receptor-mediated Ca2+influx and
release. Vascul Pharmacol. 45:171–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhu XM, Fang LH, Li YJ and Du GH:
Endothelium-dependent and -independent relaxation induced by
pinocembrin in rat aortic rings. Vascul Pharmacol. 46:160–165.
2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Rubanyi GM: The role of endothelium in
cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol.
22:(Suppl 4). S1–S14. 1993. View Article : Google Scholar : PubMed/NCBI
|
17
|
Nelson MT and Quayle JM: Physiological
roles and properties of potassium channels in arterial smooth
muscle. Am J Physiol. 268:C799–C822. 1995.PubMed/NCBI
|
18
|
Bolotina VM, Najibi S, Palacino JJ, Pagano
PJ and Cohen RA: Nitric oxide directly activates calcium-dependent
potassium channels in vascular smooth muscle. Nature. 368:850–853.
1994. View Article : Google Scholar : PubMed/NCBI
|
19
|
Jackson WF: Potassium channelsin the
peripheral microcirculation. Microcirculation. 12:113–127. 2005.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Brayden JE: Potassium channels in vascular
smooth muscle. Clin Exp Pharmacol Physiol. 23:1069–1076. 1996.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Vergara C, Latorre R, Marrion NV and
Adelman JP: Calcium-activated potassium channels. Curr Opin
Neurobiol. 8:321–329. 1998. View Article : Google Scholar : PubMed/NCBI
|
22
|
Horowitz A, Menice CB, Laporte R and
Morgan KG: Mechanisms of smooth muscle contraction. Physiol Rev.
76:967–1003. 1996.PubMed/NCBI
|
23
|
Hirata S, Enoki T, Kitamura R, Vinh VH,
Nakamura K and Mori K: Effects of isoflurane on receptor-operated
Ca2+ channels in rat aortic smooth muscle. Br J Anaesth.
81:578–583. 1998. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lee CH, Poburko D, Sahota P, Sandhu J,
Ruehlmann DO and van Breemen C: The mechanism of
phenylephrine-mediated [Ca(2+)](i) oscillations underlying tonic
contraction in the rabbit inferior vena cava. J Physiol.
534:641–650. 2001. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lee CN, Wong KL, Liu JC, Chen YJ, Cheng JT
and Chan P: Inhibitory effect of stevioside on calcium influx to
produce antihypertension. Planta Med. 67:796–799. 2001. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tanaka Y and Tashjian AH Jr: Thimerosal
potentiates Ca2+ release mediated by both the inositol
1,4,5-trisphosphate and the ryanodine receptors in sea urchin eggs.
Implications for mechanistic studies on Ca2+ signaling.
J Biol Chem. 269:11247–11253. 1994.PubMed/NCBI
|
27
|
Eckert RE, Karsten AJ, Utz J and Ziegler
M: Regulation of renal artery smooth muscle tone by
alpha1-adrenoceptors: Role of voltage-gated calcium channels and
intracellular calcium stores. Urol Res. 28:122–127. 2000.
View Article : Google Scholar : PubMed/NCBI
|